Health Chat for Empowerment-based Lifestyle Planning for Cardiometabolic Multimorbidity
HcELP_CMM
1 other identifier
interventional
232
1 country
3
Brief Summary
The goal of this study is to:
- 1.assess the feasibility, acceptability, and the preliminary effects of the health chat for empowerment-based lifestyle planning for CMM (HcELP\_CMM);
- 2.examine the short-term effects of the HcELP\_CMM program on lifestyle behaviors, cardiometabolic indicators, symptom burden, health related quality of life (HRQoL), psychological well-being, and physical function in patients with CMM;
- 3.examine the long-term effects of the HcELP\_CMM program on lifestyle behaviors, cardiometabolic indicators, symptom burden, HRQoL, psychological well-being, and physical function in patients with CMM.
- 4.If the HcELP\_CMM program is feasible and acceptable?
- 5.If the HcELP\_CMM program has the potential to improve the lifestyle behaviors, cardiometabolic indicators, symptom burden, HRQoL, psychological well-being, and physical function in patients with CMM compared to the usual care group in the short-term?
- 6.If the HcELP\_CMM program has the potential to improve the lifestyle behaviors, cardiometabolic indicators, symptom burden, HRQoL, psychological well-being, and physical function in patients with CMM compared to the usual care group in the long-term?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2025
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 21, 2025
CompletedFirst Posted
Study publicly available on registry
September 8, 2025
CompletedStudy Start
First participant enrolled
September 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 5, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 5, 2027
May 11, 2026
May 1, 2026
1.4 years
August 21, 2025
May 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (13)
Eligibility rate
Eligibility rate will only be measured in the pilot part,which will be calculated as eligible participants divided by screened participants.
Eligibility rate will be assessed at baseline only in the pilot part.
Recruitment rate
Recruitment rate will only be measured in the pilot part, which will be calculated as randomized participants divided by eligible participants.
Recruitment rate will be assessed at baseline only in the pilot part.
Adherence rate
Adherence rate will only be measured in the pilot part, which will be calculated as participants who completed the program divided by randomized participants.
Adherence rate will be assessed through study completion (an average of 12 weeks) in the pilot part only.
Reasons for refusal to participate the program
Reasons for refusal to participate the program will only be measured in the pilot part, which will be obtained from individual review.
Reasons for refusal to participate the program will be assessed at baseline only in the pilot part.
Participant's engagement experiences, feedback about the study design, and perceived program effects.
Participant's engagement experiences, feedback about the study design, and perceived program effects will only be measured in the pilot part, which will be explored by the individualized semi-structured qualitative interviews with participants in the HcELP\_CMM group through synchronized online video interviewing via WeChat platform.
Participant's engagement experiences, feedback about the study design, and perceived program effects will be measured within one week after the completion of the intervention only in the pilot part.
Attrition rate
Attrition rate will only be measured in the pilot part, which will be calculated as participants dropping out divided by randomized participants.
Attrition rate will be assessed through study completion (an average of 12 weeks) in the pilot part only.
Engagement rate
Engagement rate will only be measured in the pilot part, which will be calculated as the number of sessions of structed activities participants attended.
Engagement rate will be assessed through study completion (an average of 12 weeks) in the pilot part only.
Reasons of non-engagement
Reasons of non-engagement will only be measured in the pilot part, which will be obtained from individual review.
Reasons of non-engagement will be assessed through study completion (an average of 12 weeks) in the pilot part only.
Exposure to empowerment videos
Exposure to empowerment videos will only be measured in the pilot part, which will be calculated as ratio of views to videos distributed.
Exposure to empowerment videos will be assessed through study completion (an average of 12 weeks) in the pilot part only.
Completion rate
Completion rate will only be measured in the pilot part, which will be calculated as proportion of participants attending ≥80% of planned structured sessions.
Completion rate will be assessed through study completion (an average of 12 weeks) in the pilot part only.
Goal attainment level
Goal attainment level will only be measured in the pilot part, which will be calculated from submitted lifestyle self-evaluation logbooks.
Goal attainment level will be assessed through study completion (an average of 12 weeks) in the pilot part only.
Researcher-participant dialogues
Researcher-participant dialogues will only be measured in the pilot part, which will be analyzed from the recordings in WeChat.
Researcher-participant dialogues will be assessed through study completion (an average of 12 weeks) in the pilot part only.
Adverse events
Adverse events will only be measured in the pilot part, which will be monitored throughout the intervention via self-reported adverse events.
Adverse events will be assessed through study completion (an average of 12 weeks) in the pilot part only.
Secondary Outcomes (25)
Lifestyle behaviors
In the pilot part, this outcome will be assessed at baseline and within one week post-intervention. In the full RCT part, an additional measurement will be conducted within one week after the completion of the two-month follow-up period.
Blood pressure
In the pilot part, this outcome will be assessed at baseline and within one week post-intervention. In the full RCT part, an additional measurement will be conducted within one week after the completion of the two-month follow-up period.
Capillary fasting plasma glucose
In the pilot part, this outcome will be assessed at baseline and within one week post-intervention. In the full RCT part, an additional measurement will be conducted within one week after the completion of the two-month follow-up period.
Waist circumference
In the pilot part, this outcome will be assessed at baseline and within one week post-intervention. In the full RCT part, an additional measurement will be conducted within one week after the completion of the two-month follow-up period.
Body Mass Index
In the pilot part, this outcome will be assessed at baseline and within one week post-intervention. In the full RCT part, an additional measurement will be conducted within one week after the completion of the two-month follow-up period.
- +20 more secondary outcomes
Study Arms (2)
HcELP_CMM
EXPERIMENTALParticipants in the arm will attend a 12-week HcELP\_CMM program. This program is a hybrid intervention involving two phases: 1) face-to-face goal-oriented health counseling (week 1); 2) WeChat-based enhanced healthy lifestyle empowerment delivered by WeChat platform utilizing the official account, chat function, and synchronized online videos to integrate and sustain healthy lifestyle (weekly, week 2-12). Phase 1 covers 4 core steps: 1) risk diagnostics; 2) risk communication; 3) goal setting; and 4)strengthen commitment to lifestyle change. Phase 2 covers two modules: 1) lifestyle change for better, and 2) effective lifestyle maintenance.
Usual care
ACTIVE COMPARATORParticipants in the arm will receive usual care provided by the CHCCs, which will include general health education on preventing and managing common diseases. They will not receive any components of the empowerment-based intervention.
Interventions
Participants in this group will receive usual care provided by the CHCCs, which will include general health education on preventing and managing common diseases. They will not receive any components of the empowerment-based intervention.
Participants in this group will attend a 12-week HcELP\_CMM program. This program is a hybrid intervention involving two phases: 1) face-to-face goal-oriented health counseling (week 1); 2) WeChat-based enhanced healthy lifestyle empowerment delivered by WeChat platform utilizing the official account, chat function, and synchronized online videos to integrate and sustain healthy lifestyle (weekly, week 2-12). Phase 1 covers 4 core steps: 1) risk diagnostics; 2) risk communication; 3) goal setting; and 4)strengthen commitment to lifestyle change. Phase 2 covers two modules: 1) lifestyle change for better, and 2) effective lifestyle maintenance.
Eligibility Criteria
You may qualify if:
- Adults aged 18 years or above;
- Diagnosed with cardiometabolic multimorbidity (CMM), which was defined as co-existing with two or more cardiometabolic diseases, including primary hypertension, type 2 diabetes, stroke, heart diseases (eg. coronary heart disease, arrhythmia, heart failure, myocardial infarction, and cardiac valve diseases), dyslipidemia, and obesity;
- Possessed a digital device installed with WeChat, as well as with an internet connection.
You may not qualify if:
- Contraindications to exercise according to American College of Sports Medicine (ACSM), such as severe musculoskeletal disorders, severe cardiovascular diseases, or spinal nerve injury;
- Diagnosis of psychiatric disease;
- Has impaired cognitive function as indicated by an Abbreviated Mental Test Score (AMTS) ≤6;
- Has impaired sensory or communication function which hider them participation in this program, such as hearing loss, vision loss, and unable to speak Mandarin.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Gusu District Feng Men Street Community Health Service Center
Suzhou, Jiangsu, 215000, China
Gusu District Jinchang Street Bailian Community Health Service Center
Suzhou, Jiangsu, 215000, China
Gusu District Shuang Ta Street Jinfan Community Health Service Center
Suzhou, Jiangsu, 215000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jing Xi, PhD
The University of Hong Kong
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Masking Description
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
August 21, 2025
First Posted
September 8, 2025
Study Start
September 8, 2025
Primary Completion (Estimated)
February 5, 2027
Study Completion (Estimated)
February 5, 2027
Last Updated
May 11, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share